April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
The Societal Burden of Blindness Secondary to Retinopathy of Prematurity in Lima, Peru
Author Affiliations & Notes
  • Hreem B. Dave
    Department of Ophthalmology, Emory University, Atlanta, Georgia
  • Luz Gordillo
    Department of Ophthalmology, Hospital Nacional Edgardo Rebagliati Martins EsSalud, Lima, Peru
  • Zhou Yang
    Health Policy and Management, Rollins School of Public Health, Atlanta, Georgia
  • Monica S. Zhang
    Department of Ophthalmology, Emory University, Atlanta, Georgia
  • Timothy W. Olsen
    Department of Ophthalmology, Emory University, Atlanta, Georgia
  • Footnotes
    Commercial Relationships  Hreem B. Dave, None; Luz Gordillo, None; Zhou Yang, None; Monica S. Zhang, None; Timothy W. Olsen, None
  • Footnotes
    Support  Unrestricted Grant from Research to Prevent Blindness, Emory Glocal Vision Initiative, Emory University School of Medicine
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3152. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hreem B. Dave, Luz Gordillo, Zhou Yang, Monica S. Zhang, Timothy W. Olsen; The Societal Burden of Blindness Secondary to Retinopathy of Prematurity in Lima, Peru. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3152.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To determine the cost effectiveness of laser treatment for retinopathy of prematurity (ROP) in Peru in comparison to no intervention.

Methods: : The direct cost of treatment and the indirect lifetime cost of neonatal-onset blindness to the society were estimated. The direct cost of ROP-related treatment was determined using data from a social security sector hospital NICU, including the amortized cost of equipment, labor cost, medication, and follow up care. The Peruvian national economic data, frequency of blindness from ROP, per capita gross domestic product, gender adjusted income distribution, life-expectancy adjustment, and average years spent in the work force were used to calculate indirect costs. Indirect costs per child that were avoided by treatment were calculated using outcomes from the CRYO-ROP and ETROP studies. Total cost savings per child was determined.

Results: : For ROP-related neonatal blindness in Peru, we estimate the total indirect cost at $79,101 (USD) per child while the direct cost of treatment with a diode laser per child is $2,496. The societal lifetime cost saving per child is $76,605 with laser treatment.

Conclusions: : The societal burden of blindness far exceeds the costs of treatment per child. Since the mean annual income per educated adult in Peru is $8,000, treatment of a single child is equivalent to employing nine, full-time educated adults for an entire year. Proper screening and treatment of ROP prevents blindness and leads to substantial cost saving for society. Therefore, increasing support for early screening, treatment and prevention of ROP is significantly cost-effective and prevents unnecessary blindness.

Keywords: retinopathy of prematurity • clinical (human) or epidemiologic studies: health care delivery/economics/manpower • clinical (human) or epidemiologic studies: prevalence/incidence 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.